Bullboard - Stock Discussion Forum Syros Pharmaceuticals Inc SYRS

Healthcare Biotechnology

Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing new standards of care for the frontline treatment of patients with hematologic malignancies. The Company is advancing Tamibarotene, a selective retinoic acid receptor alpha (RARa), agonist for which the Company is conducting SELECT-MDS-1, a Phase III clinical trial evaluating tamibarotene in... see more

Add To Watchlist

NDAQ:SYRS - Post Discussion

Syros Pharmaceuticals Inc > Bronstein, Gewirtz and Grossman, LLC Encourages Syros Pharma

View:

Post by whytestocks on Aug 29, 2024 1:45pm

Bronstein, Gewirtz and Grossman, LLC Encourages Syros Pharma

Just In: $SYRS Bronstein, Gewirtz and Grossman, LLC Encourages Syros Pharmaceuticals, Inc. (SYRS) Stockholders to Inquire about Securities InvestigationNEW YORK CITY, NY / ACCESSWIRE / August 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Syros Pharmaceuticals, Inc. ("Syros" or "the Company") (NASDAQ:SYRS). Investors who purchased Syros securities are encouraged to obtain additiona...SYRS - Bronstein, Gewirtz and Grossman, LLC Encourages Syros Pharmaceuticals, Inc. (SYRS) Stockholders to Inquire about Securities Investigation

165